Eligard and Memory loss - a phase IV clinical study of FDA data
Summary:
Memory loss is reported as a side effect among people who take Eligard (leuprolide acetate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Xtandi, and have Prostate cancer metastatic.
The phase IV clinical study analyzes which people have Memory loss when taking Eligard. It is created by eHealthMe based on reports of 44,585 people who have side effects when taking Eligard from the FDA, and is updated regularly.
What is Eligard?
Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. eHealthMe is studying from 44,652 Eligard users. Check the latest studies of Eligard.
What is Memory loss?
Memory loss is found to be associated with 2,730 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.
44,585 people reported to have side effects when taking Eligard.
Among them, 301 people (0.68%) have Memory loss.
Among these 301 people:
How long have people been on Eligard when they have Memory loss? *
What is the gender of people who have Memory loss when taking Eligard? *
What is the age of people who have Memory loss when taking Eligard? *
What are other drugs people take besides Eligard? *
What are other side effects people have besides Memory loss? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Eligard and have Memory loss?
- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Eligard:
- Eligard (44,652 reports)
Memory loss treatments and more:
- Memory loss (244,444 reports)
How severe was Memory loss and when was it recovered:
Expand to all the drugs that have ingredients of leuprolide acetate:
- Memory loss and drugs with ingredients of leuprolide acetate (1,491 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Eligard:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Memory loss:
- Memory loss (2,730 drugs)
Browse all the conditions that are associated with Memory loss:
- Memory loss (4,375 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Eligard) and Eligard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Eliquis and Amlodipine - 4 seconds ago
- Keppra vs. Namenda, side effect and effectiveness comparison - 4 seconds ago
- Could Leucovorin Calcium cause Sepsis? - 6 seconds ago
- Drug interactions of Clotrimazole And Betamethasone Dipropionate and Lorazepam - 10 seconds ago
- Cyclosporine and Febrile Neutropenia for Women aged 30-39 - 17 seconds ago
- Drug interactions of Buprenorphine and Buspirone Hcl - 20 seconds ago
- Could Flomax cause Sputum Discolored? - 26 seconds ago
- Sunosi and Stress And Anxiety for Women aged 50-59 - 36 seconds ago
- Sunosi and Anxiolytic Therapy for Women aged 50-59 - 36 seconds ago
- Sunosi and Anxiety And Stress for Women aged 50-59 - 36 seconds ago